Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors

Stopped Difficulty in recruiting subjects who meet the inclusion/exclusion criteria

Conditions

• Crohn Disease

Interventions

• DRUG: Thalidomide
• DRUG: Infliximab

Sponsor

IRCCS Burlo Garofolo

Collaborators

• [object Object]
• [object Object]